Financial reports
Current reports
6-K
Current report (foreign)
21 Mar 24
6-K
Immatics Announces Proposed Public Offering
22 Jan 24
6-K
Current report (foreign)
14 Nov 23
6-K
Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
8 Nov 23
6-K
Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
24 Oct 23
6-K
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
11 Sep 23
6-K
Current report (foreign)
17 Aug 23
6-K
Current report (foreign)
10 Aug 23
6-K
Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb
24 Jul 23
6-K
Current report (foreign)
20 Jun 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
19 Jan 24
424B5
Prospectus supplement for primary offering
17 Jan 24
424B3
Prospectus supplement
13 Sep 23
F-3
Shelf registration (foreign)
25 Aug 23
424B5
Prospectus supplement for primary offering
11 Oct 22
424B5
Prospectus supplement for primary offering
11 Oct 22
S-8
Registration of securities for employees
24 Jun 22
POS AM
Prospectus update (post-effective amendment)
2 Aug 21
F-3
Shelf registration (foreign)
2 Aug 21
424B3
Prospectus supplement
22 Jun 21
Proxies
No filings
Other
EFFECT
Notice of effectiveness
14 Sep 23
CORRESP
Correspondence with SEC
11 Sep 23
UPLOAD
Letter from SEC
29 Aug 23
EFFECT
Notice of effectiveness
10 Aug 21
EFFECT
Notice of effectiveness
6 Aug 21
CORRESP
Correspondence with SEC
6 Aug 21
UPLOAD
Letter from SEC
6 Aug 21
UPLOAD
Letter from SEC
30 Jul 21
CORRESP
Correspondence with SEC
21 Jul 21
UPLOAD
Letter from SEC
1 Jul 21
Ownership
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 24
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
ATHOS KG
7 Feb 24
SC 13G/A
ATHOS KG
7 Feb 24
SC 13G
ATHOS KG
16 Aug 23
SC 13G/A
Nantahala Capital Management, LLC
14 Feb 23
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 23
SC 13G/A
dievini Hopp BioTech holding GmbH & Co KG
10 Feb 23
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
7 Feb 23
SC 13G
Nantahala Capital Management, LLC
14 Feb 22